Publications

  1. Chedid V, Vijayvargiya P, Carlson P, Van Malderen K, Acosta A, Zinsmeister A, Camilleri M. Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study. Neurogastroenterol Motil. 2018 Feb 28 [Epub ahead of print]
    View PubMed
  2. Vargas EJ, Pesta CM, Bali A, Ibegbu E, Bazerbachi F, Moore RL, Kumbhari V, Sharaiha RZ, Curry TW, DosSantos G, Schmitz R, Agnihotri A, Novikov AA, Pitt T, Dunlap MK, Herr A, Aronne L, Ledonne E, Kadouh HC, Cheskin LJ, Mundi MS, Acosta A, Gostout CJ, Abu Dayyeh BK. Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-World Population. Clin Gastroenterol Hepatol. 2018 Feb 7 Epub 2018 Feb 07
    View PubMed
  3. Halawi H, Vijayvargiya P, Busciglio I, Oduyebo I, Khemani D, Ryks M, Rhoten D, Burton D, Szarka LA, Acosta A, Camilleri M. Effects of naloxegol on whole gut transit in opioid-naive healthy subjects receiving codeine: A randomized, controlled trial. Neurogastroenterol Motil. 2018 Feb 6 Epub 2018 Feb 06
    View PubMed
  4. Vargas EJ, Bazerbachi F, Rizk M, Rustagi T, Acosta A, Wilson EB, Wilson T, Neto MG, Zundel N, Mundi MS, Collazo-Clavell ML, Meera S, Abu-Lebdeh HS, Lorentz PA, Grothe KB, Clark MM, Kellogg TA, McKenzie TJ, Kendrick ML, Topazian MD, Gostout CJ, Abu Dayyeh BK. Transoral outlet reduction with full thickness endoscopic suturing for weight regain after gastric bypass: a large multicenter international experience and meta-analysis. Surg Endosc. 2018 Jan; 32 (1):252-259 Epub 2017 June 29
    View PubMed
  5. Halawi H, Khemani D, Eckert D, O'Neill J, Kadouh H, Grothe K, Clark MM, Burton DD, Vella A, Acosta A, Zinsmeister AR, Camilleri M. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial. Lancet Gastroenterol Hepatol. 2017 Dec; 2 (12):890-899 Epub 2017 Sept 27
    View PubMed
  6. Pajot G, Calderon G, Acosta A. Endoscopic Treatments for Obesity. Curr Treat Options Gastroenterol. 2017 Dec; 15 (4):660-675
    View PubMed
  7. Halawi H, Camilleri M, Acosta A, Vazquez-Roque M, Oduyebo I, Burton D, Busciglio I, Zinsmeister AR. Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in health. Am J Physiol Gastrointest Liver Physiol. 2017 Nov 1; 313 (5):G442-G447 Epub 2017 Aug 03
    View PubMed
  8. Park SY, Acosta A, Camilleri M, Burton D, Harmsen WS, Fox J, Szarka LA. Gastric Motor Dysfunction in Patients With Functional Gastroduodenal Symptoms. Am J Gastroenterol. 2017 Nov; 112 (11):1689-1699 Epub 2017 Sept 12
    View PubMed
  9. Lopez-Nava G, Sharaiha RZ, Vargas EJ, Bazerbachi F, Manoel GN, Bautista-Castano I, Acosta A, Topazian MD, Mundi MS, Kumta N, Kahaleh M, Herr AM, Shukla A, Aronne L, Gostout CJ, Abu Dayyeh BK. Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up. Obes Surg. 2017 Oct; 27 (10):2649-2655
    View PubMed
  10. Nelson AD, Camilleri M, Acosta A, Boldingh A, Busciglio I, Burton D, Ryks M, Zinsmeister AR. A single-center, prospective, double-blind, sham-controlled, randomized study of the effect of a vibrating capsule on colonic transit in patients with chronic constipation. Neurogastroenterol Motil. 2017 Jul; 29 (7) Epub 2017 Feb 08
    View PubMed
  11. Park SY, Khemani D, Acosta A, Eckert D, Camilleri M. Rectal gas volume: Defining cut-offs for screening for evacuation disorders in patients with constipation. Neurogastroenterol Motil. 2017 Jul; 29 (7) Epub 2017 Mar 06
    View PubMed
  12. Khemani D, Camilleri M, Roldan A, Nelson AD, Park SY, Acosta A, Zinsmeister AR. Opioid analgesic use among patients presenting with acute abdominal pain and factors associated with surgical diagnoses. Neurogastroenterol Motil. 2017 May; 29: (5).
    View PubMed
  13. Camilleri M, Malhi H, Acosta A. Gastrointestinal Complications of Obesity. Gastroenterology. 2017 May; 152 (7):1656-1670 Epub 2017 Feb 10
    View PubMed
  14. Acosta A, Streett S, Kroh MD, Cheskin LJ, Saunders KH, Kurian M, Schofield M, Barlow SE, Aronne L. White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education, and Resources. Clin Gastroenterol Hepatol. 2017 May; 15 (5):631-649.e10 Epub 2017 Feb 27
    View PubMed
  15. Valentin N, Camilleri M, Carlson P, Harrington SC, Eckert D, O'Neill J, Burton D, Chen J, Shaw AL, Acosta A. Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome. Physiol Rep. 2017 Mar; 5 (5)
    View PubMed
  16. Abu Dayyeh BK, Acosta A, Camilleri M, Mundi MS, Rajan E, Topazian MD, Gostout CJ. Endoscopic Sleeve Gastroplasty Alters Gastric Physiology and Induces Loss of Body Weight in Obese Individuals. Clin Gastroenterol Hepatol. 2017 Jan; 15 (1):37-43.e1 Epub 2015 Dec 31
    View PubMed
  17. Acosta A, Camilleri M. A working paradigm for the treatment of obesity in gastrointestinal practice. Tech Gastrointest Endosc. 2017 Jan; 19 (1):52-60 Epub 2017 Jan 25
    View PubMed
  18. Kadouh HC, Acosta A. Current paradigms in the etiology of obesity Techniques In Gastrointestinal Endoscopy. 2017 Jan; 19 (1):2-11
  19. Valentin N, Camilleri M, Altayar O, Vijayvargiya P, Acosta A, Nelson AD, Murad MH. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis. Gut. 2016 Dec; 65 (12):1951-1959 Epub 2015 Sept 07
    View PubMed
  20. Valentin N, Camilleri M, Altayar O, Vijayvargiya P, Acosta A, Nelson AD, Murad MH. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis Gut. 2016 Dec; 65: (12)1951-U170.
  21. Iturrino J, Camilleri M, Acosta A, O'Neill J, Burton D, Edakkanambeth Varayil J, Carlson PJ, Zinsmeister AR, Hurt R. Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition. JPEN J Parenter Enteral Nutr. 2016 Nov; 40 (8):1089-1095 Epub 2015 July 28
    View PubMed
  22. Nelson AD, Camilleri M, Acosta A, Busciglio I, Linker Nord S, Boldingh A, Rhoten D, Ryks M, Burton D. Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers. Neurogastroenterol Motil. 2016 Nov; 28 (11):1705-1713 Epub 2016 June 09
    View PubMed
  23. Camilleri M, Carlson P, Valentin N, Acosta A, O'Neill J, Eckert D, Dyer R, Na J, Klee EW, Murray JA. Pilot study of small bowel mucosal gene expression in patients with irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol. 2016 Sep 01; 311 (3):G365-76 Epub 2016 July 21
    View PubMed
  24. Acosta A, Camilleri M, Shin A, Vazquez-Roque MI, Iturrino J, Carlson P, Vella A, Zinsmeister AT, de M. Association of obesity-related genes with quantitative gastrointestinal traits in obesity Genes and Nutrition.2016;().
  25. Mouchli MA, Camilleri M, Lee T, Parthasarathy G, Vijayvargiya P, Halland M, Acosta A, Bharucha AE. Evaluating the safety and the effects on colonic compliance of neostigmine during motility testing in patients with chronic constipation. Neurogastroenterol Motil. 2016 Jun; 28 (6):871-8 Epub 2016 Feb 03
    View PubMed
  26. Acosta A, Camilleri M, Shin A, Linker Nord S, O'Neill J, Gray AV, Lueke AJ, Donato LJ, Burton DD, Szarka LA, Zinsmeister AR, Golden PL, Fodor A. Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. Clin Transl Gastroenterol. 2016 May 26; 7:e173.
    View PubMed
  27. Acosta A, Camilleri M, Busciglio I, Boldingh A, Nelson AD, Burton D. Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial. Dig Dis Sci. 2016 Mar; 61 (3):852-60 Epub 2015 Oct 14
    View PubMed
  28. Acosta A, Camilleri M, Linker-Nord S, Busciglio I, Iturrino J, Szarka LA, Zinsmeister AR. A Pilot Study of the Effect of Daikenchuto on Rectal Sensation in Patients with Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2016 Jan 31; 22: (1)69-77.
    View PubMed
  29. Camilleri M, Acosta A. Gastrointestinal traits: individualizing therapy for obesity with drugs and devices. Gastrointest Endosc. 2016 Jan; 83: (1)48-56.
    View PubMed
  30. Acosta A, Camilleri M, Shin A, Carlson P, Burton D, O'Neill J, Eckert D, Zinsmeister A. Associations of variations of 5-HT2c receptor genes with satiation in overweight and obese adults Appetite.2016;().
  31. Acosta A, Camilleri M, Kolar G, Iturrino J, Szarka LA, Boldingh A, Burton D, Ryks M, Rhoten D, Zinsmeister AR, Spence SC, Gottesdiener K, Bouras EP, Vazquez-Roque MI. Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial. Clin Gastroenterol Hepatol. 2015 Dec; 13: (13)2312-9.e1.
    View PubMed
  32. Nelson AD, Mouchli MA, Valentin N, Deyle D, Pichurin P, Acosta A, Camilleri M. Ehlers Danlos syndrome and gastrointestinal manifestations: a 20-year experience at Mayo Clinic. Neurogastroenterol Motil. 2015 Nov; 27: (11)1657-66.
    View PubMed
  33. Acosta A, Camilleri M, Burton D, O'Neill J, Eckert D, Carlson P, Zinsmeister AR. Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study. Physiol Rep. 2015 Nov; 3: (11).
    View PubMed
  34. O'Dwyer RH, Acosta A, Camilleri M, Burton D, Busciglio I, Bharucha AE. Clinical Features and Colonic Motor Disturbances in Chronic Megacolon in Adults. Dig Dis Sci. 2015 Aug; 60: (8)2398-407.
    View PubMed
  35. Camilleri M, Carlson P, Acosta A, Busciglio I. Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion. Am J Physiol Gastrointest Liver Physiol. 2015 Jul 01; 309: (1)G10-20.
    View PubMed
  36. Ryan D, Acosta A. GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond. Obesity (Silver Spring). 2015 Jun; 23: (6)1119-29.
    View PubMed
  37. Valentin N, Acosta A, Camilleri M. Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials. Expert Opin Investig Drugs. 2015 Jun; 24: (6)769-79.
    View PubMed
  38. Shin A, Acosta A, Camilleri M, Boldingh A, Burton D, Ryks M, Rhoten D, Zinsmeister AR. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation. Clin Gastroenterol Hepatol. 2015 Apr; 13: (4)701-8.e1.
    View PubMed
  39. Acosta A, Camilleri M, Shin A, Vazquez-Roque MI, Iturrino J, Lanza IR, Nair KS, Burton D, O'Neill J, Eckert D, Carlson P, Vella A, Zinsmeister AR. Association of UCP-3 rs1626521 with obesity and stomach functions in humans. Obesity (Silver Spring). 2015 Apr; 23: (4)898-906.
    View PubMed
  40. Acosta A, Camilleri M, Shin A, Vazquez-Roque MI, Iturrino J, Burton D, O'Neill J, Eckert D, Zinsmeister AR. Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy. Gastroenterology. 2015 Mar; 148: (3)537-546.e4.
    View PubMed
  41. Camilleri M, Acosta A. Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist. Neurogastroenterol Motil. 2015 Mar; 27: (3)324-32.
    View PubMed
  42. Camilleri M, Acosta A, Busciglio I, Boldingh A, Dyer RB, Zinsmeister AR, Lueke A, Gray A, Donato LJ. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2015 Mar; 41: (5)438-48.
    View PubMed
  43. Acosta A, Camilleri M. Prokinetics in gastroparesis. Gastroenterol Clin North Am. 2015 Mar; 44: (1)97-111.
    View PubMed
  44. Acosta A, Camilleri M. Invited editorial: Pharmacogenetics in irritable bowel syndrome Exp Opin Drug Metab Toxicol.2015;().
  45. Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha AE, Burton D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil. 2014 Dec; 26: (12)1677-85.
    View PubMed
  46. Acosta A, Azzalin A, Emmons CJ, Shuster JJ, Jay M, Lo MC. Improving residents' clinical approach to obesity: impact of a multidisciplinary didactic curriculum. Postgrad Med J. 2014 Nov; 90: (1069)630-7.
    View PubMed
  47. Camilleri M, Busciglio I, Acosta A, Shin A, Carlson P, Burton D, Ryks M, Rhoten D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea. Am J Gastroenterol. 2014 Oct; 109: (10)1621-30.
    View PubMed
  48. Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha AE, Burton D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion. Am J Physiol Gastrointest Liver Physiol. 2014 Sep 1; 307: (5)G508-16.
    View PubMed
  49. Acosta A, Camilleri M. Elobixibat and its potential role in chronic idiopathic constipation. Therap Adv Gastroenterol. 2014 Jul; 7: (4)167-75.
    View PubMed
  50. Camilleri M, Carlson P, Acosta A, Busciglio I, Nair AA, Gibbons SJ, Farrugia G, Klee EW. RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study. Am J Physiol Gastrointest Liver Physiol. 2014 Jun 15; 306: (12)G1089-98.
    View PubMed
  51. Acosta A, Abu Dayyeh BK, Port JD, Camilleri M. Recent advances in clinical practice challenges and opportunities in the management of obesity. Gut. 2014 Apr; 63: (4)687-95.
    View PubMed
  52. Acosta A, Camilleri M. Gastrointestinal morbidity in obesity. Ann N Y Acad Sci. 2014 Apr; 1311:42-56.
    View PubMed
  53. Acosta A, Camilleri M, Shin A, Carlson P, Burton D, O'Neill J, Eckert D, Zinsmeister AR. Association of melanocortin 4 receptor gene variation with satiation and gastric emptying in overweight and obese adults. Genes Nutr. 2014 Mar; 9: (2)384.
    View PubMed
  54. Bick BL, Acosta Cardenas AJ, Vege SS. 52-year-old man with acute midabdominal pain. Mayo Clin Proc. 2014 Jan; 89: (1)115-9.
    View PubMed
  55. Hurtado MD, Sergeyev VG, Acosta A, Spegele M, La Sala M, Waler NJ, Chiriboga-Hurtado J, Currlin SW, Herzog H, Dotson CD, Gorbatyuk OS, Zolotukhin S. Salivary peptide tyrosine-tyrosine 3-36 modulates ingestive behavior without inducing taste aversion. J Neurosci. 2013 Nov 20; 33: (47)18368-80.
    View PubMed
  56. Anton SD, Heekin K, Simkins C, Acosta A. Differential effects of adulterated versus unadulterated forms of linoleic acid on cardiovascular health. J Integr Med. 2013 Jan; 11: (1)2-10.
    View PubMed
  57. Polyak S, Mach A, Porvasnik S, Dixon L, Conlon T, Erger KE, Acosta A, Wright AJ, Campbell-Thompson M, Zolotukhin I, Wasserfall C, Mah C. Identification of adeno-associated viral vectors suitable for intestinal gene delivery and modulation of experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2012 Feb 1; 302: (3)G296-308.
    View PubMed
  58. Hurtado MD, Acosta A, Riveros PP, Baum BJ, Ukhanov K, Brown AR, Dotson CD, Herzog H, Zolotukhin S. Distribution of Y-receptors in murine lingual epithelia. PLoS One. 2012; 7: (9)e46358.
    View PubMed
  59. Acosta A, Hurtado MD, Gorbatyuk O, La Sala M, Duncan D, Aslanidi G, Campbell-Thompson M, Zhang L, Herzog H, Voutetakis A, Baum BJ, Zolotukhin S. Salivary PYY: a putative bypass to satiety. PLoS One. 2011; 6: (10)e26137.
    View PubMed
  60. Paz-y-Mino C, Fiallo BF, Morillo SA, Acosta A, Gimenez P, Ocampo L, Leone PE. Analysis of the polymorphism [gIVS12-6T > C] in the hMSH2 gene in lymphoma and leukemia. Leuk Lymphoma. 2003 Mar; 44: (3)505-8.
    View PubMed